Transcriptomic profiling of [177lu]lu-PSMA-I&T and [225Ac]Ac-PSMA-I&T treated prostate cancer cells: insights into dynamic responses
Authors:
- Mariangela SabatellaMSMariangela Sabatella
- José María Heredia-GenestarJHJosé María Heredia-Genestar
- Eline HooijmanEHEline Hooijman
- Erik de BloisEBErik de Blois
- Julie NonnekensJNJulie Nonnekens
Open Access
- 9 October 2026
- journal article
- Published by Elsevier in EANM Innovation
- Vol. 5
Abstract
No abstract availableFunding Information
- Eli Lilly and Company
This publication has 45 references indexed in Scilit:
- Preclinical comparison of radiobiological and radiosensitizing effects in peptide receptor radionuclide therapy and external beam radiotherapyEANM Innovation, 2026
- Epithelial–Mesenchymal Transition in Cancer: Insights Into Therapeutic Targets and Clinical ImplicationsMedcomm, 2025
- PSMA targeted Therapy: From molecular mechanisms to clinical breakthroughs in castration-resistant prostate cancerEuropean Journal of Medicinal Chemistry, 2025
- PSMA-targeted radioligand therapy in metastatic prostate cancer: Comprehensive analysis of recent evidenceEuropean Journal of Nuclear Medicine and Molecular Imaging, 2024
- Theranostics in oncology: What radiologists want to knowEuropean Journal of Radiology, 2021
- Prostate-specific Membrane Antigen Heterogeneity and DNA Repair Defects in Prostate CancerEuropean Urology, 2019
- The DNA damage-induced cell death response: a roadmap to kill cancer cellsCellular and Molecular Life Sciences, 2016
- The Molecular Signatures Database Hallmark Gene Set CollectionCell Systems, 2015
- Radiation-enhanced cell migration/invasion process: A reviewCritical Reviews in Oncology/Hematology, 2014
- Heterogeneity of Prostate-Specific Membrane Antigen (PSMA) Expression in Prostate Carcinoma with Distant MetastasisPathology and Oncology Research, 2008